DT&CRO Co

DT&CRO Co Rule of 40

The Rule of 40 of DT&CRO Co (383930.KQ) as of Oct 20, 2026 is 1,220.23 %. In the previous year, Rule of 40 was -35.71 % — a change of -3,516.64% (higher).

Rule of 40

1,220.23 %

YoY

-3,516.64%

Last updated:

Rule of 40 of DT&CRO Co is 2022 1,220.23 % . Rule of 40 of DT&CRO Co was 2021 -35.71 % . It decreases by -3,516.64% higher compared to the previous year.

The DT&CRO Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
91.63 KRW
Jan 1, 2020
78.00 KRW
Jan 1, 2021
-35.71 KRW
Jan 1, 2022
1,220.23 KRW
The DT&CRO Co Rule of 40 history
YEARRule of 40YoY
1,220.23 %-3,516.64%
-35.71 %-145.79%
78.00 %-14.87%
91.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DT&CRO Co Stock analysis

What does DT&CRO Co do? DT&CRO Co Ltd is a South Korean company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Based in Yongin, the company has 277 employees and completed its initial public offering (IPO) on November 11, 2022. DT&CRO Co Ltd provides non-clinical and clinical trial services for pharmaceuticals, medical devices, food, chemicals, and cosmetics. The company also offers analysis, efficacy evaluation, and related services. Its headquarters are located in Yongin, Gyeonggi-Do, South Korea. The company's website is www.dtncro.com. DT&CRO Co Ltd is engaged in research and development activities related to medicine and pharmaceuticals, though specific details about its R&D focus or product offerings are not provided in the available information. The company operates as a service provider in the life sciences sector, supporting various industries through trial services and analytical solutions. As a publicly traded company, it is listed under the ticker symbol 383930.KQ with ISIN KR7383930005. The company's operations are centered on delivering specialized services to clients in the pharmaceutical and related industries, emphasizing both non-clinical and clinical trial support. DT&CRO Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DT&CRO Co stock

Rule of 40 of DT&CRO Co is 1,220.23 % in 2022.

On Eulerpool you can find the complete historical development of Rule of 40 DT&CRO Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — DT&CRO Co

All Key Metrics — DT&CRO Co